Rolf Jautelat

Vice President Medicinal Chemistry
Bayer AG
Rolf Jautelat is VP Medicinal Chemistry at Bayer Pharmaceuticals. Throughout his career he has been involved in drug discovery projects aiming for cardiovascular drugs, targeted anti-cancer agents, antibody-drug conjugates and new ophthalmic agents. Furthermore, he was involved in the design of Chemistry Information Systems, first at Schering AG and then later at Bayer. Rolf received a Ph.D. in synthetic chemistry from the University of Hannover followed by postdoctoral studies at the Scripps Research Institute, La Jolla.


No data was found

Live Webinar

Application of In-Vitro and In-Vivo ADME/PK/Expl Tox assays to Support Lead and Candidate Selections

Wednesday, 18th November, 2020
10:00am GMT (UTC+0)

hosted by Lilly Xu, Ph.D. Senior Vice President, DMPK & Exploratory Toxicology Dept, ChemPartner

Download Brochure

Full details regarding the R&D Series are available for download in the Conference Brochure